Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OneMedNet (ONMD) Cash from Financing Activities (2022 - 2025)

OneMedNet (ONMD) has disclosed Cash from Financing Activities for 4 consecutive years, with $477000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Cash from Financing Activities fell 91.28% to $477000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $7.9 million, a 23.91% decrease, with the full-year FY2024 number at $9.1 million, up 97.14% from a year prior.
  • Cash from Financing Activities was $477000.0 for Q3 2025 at OneMedNet, up from -$100000.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $5.5 million in Q3 2024 to a low of -$100000.0 in Q4 2024.
  • A 4-year average of $1.6 million and a median of $1.4 million in 2023 define the central range for Cash from Financing Activities.
  • Biggest YoY gain for Cash from Financing Activities was 284.94% in 2024; the steepest drop was 108.5% in 2024.
  • OneMedNet's Cash from Financing Activities stood at $1.7 million in 2022, then crashed by 31.69% to $1.2 million in 2023, then plummeted by 108.5% to -$100000.0 in 2024, then skyrocketed by 577.0% to $477000.0 in 2025.
  • Per Business Quant, the three most recent readings for ONMD's Cash from Financing Activities are $477000.0 (Q3 2025), -$100000.0 (Q4 2024), and $5.5 million (Q3 2024).